Forum
The case for Option B and Optional B+: Ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality
Southern African Journal of HIV Medicine | Vol 13, No 4 | a112 |
DOI: https://doi.org/10.4102/sajhivmed.v13i4.112
| © 2012 D Besada, G Van Cutsem, E Goemaere, N Ford, H Bygrave, S Lynch
| This work is licensed under CC Attribution 4.0
Submitted: 15 December 2012 | Published: 04 October 2012
Submitted: 15 December 2012 | Published: 04 October 2012
About the author(s)
D Besada, Médecins Sans Frontières, Cape Town, South AfricaG Van Cutsem, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, and Médecins Sans Frontières, Cape Town, South Africa
E Goemaere, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, and Médecins Sans Frontières, Cape Town, South Africa
N Ford, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, and Médecins Sans Frontières, Geneva, Switzerland
H Bygrave, Médecins Sans Frontières, London, United Kingdom
S Lynch, Médecins Sans Frontières Access Campaign, New York, United States
Abstract
In a previous issue of the Southern African Journal of HIV Medicine, Pillay and Black summarised the trade-offs of the safety of efavirenz use in pregnancy (Pillay P, Black V. Safety, strength and simplicity of efavirenz in pregnancy. Southern African Journal of HIV Medicine 2012;13(1):28-33.). Highlighting the benefits of the World Health Organization’s proposed options for the prevention of mother-to-child transmission (PMTCT) of HIV, the authors argued that the South African government should adopt Option B as national PMTCT policy and pilot projects implementing Option B+ as a means of assessing the individual- and population-level effect of the intervention. We echo this call and further propose that the option to remain on lifelong antiretroviral therapy, effectively adopting PMTCT Option B+, be offered to pregnant women following the cessation of breastfeeding, for their own health, following the provision of counselling on associated benefits and risks. Here we highlight the benefits of Options B and B+.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 5251Total article views: 7482
Crossref Citations
1. Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts
Linda-Gail Bekker, Francois Venter, Karen Cohen, Eric Goemare, Gilles Van Cutsem, Andrew Boulle, Robin Wood
Antiviral Therapy vol: 19 issue: 3_suppl first page: 105 year: 2014
doi: 10.3851/IMP2905